Research grants

The SFO announces up to 11 research grants for projects within the field of stem cells and regenerative medicine. Senior research grants are open to all candidates and junior research grants are open to candidates up to 12 years after obtaining their PhD, counted until the day of the application deadline (time for parental leave, military service, and up to 5 years for internship and medical specialty training occurring after PhD can be deducted).

Eligible projects will be supported with 2 MSEK for 2021. Grants can be used to cover salaries, running costs, equipment and administrative costs. Indirect costs for the research project must not exceed the INDI level at the receiving department. Starting date for grants is May 1st, 2021. However, within an active recruitment process of an external candidate, the starting date could be delayed to December 1st, 2021 at the latest. A researcher is limited to submit only one application for a research grant or a clinical research grant, i.e. not both.

Proposals will be evaluated and ranked by external international experts within the field. Final decisions will be taken by the SFO Steering committee.

Note, if the government decides to allocate funding for 2022 to the SFOs, the 2021 grant may be followed by a second-year grant in 2022 based on the application granted in 2021, without new evaluation.

Eligible to apply

For senior grants: Principal investigator. For junior grants: Principal investigators or researchers about to start an independent research group and within 12 years after obtaining their PhD, counted until the day of the application deadline (time for parental leave, military service, and up to 5 years for internship and medical specialty training occurring after PhD can be deducted). PIs in the process of being recruited to KI and who will be employed at the latest December 1st, 2021 are also eligible, but will require a detailed letter of support by the chair of the receiving institution. A final decision about support will require that the applicant has started his or her employment at KI/SLL.  Grants will be transferred to the KI department. Applicants should have a PhD degree or equivalent and be affiliated 100% to KI and/or SLL at the time of starting the project. The proposed research program should have relevance for the field of stem cells and regenerative medicine. Applicants who received SFO Stem Cells and Regenerative Medicine research grants with a disposition right including 2021 are not eligible to apply.

Relevance

Stem cells play an important role in the development, homeostasis and regeneration of tissues. Malfunctions in stem cells may lead to several types of disease. Stem cells research is rapidly expanding our understanding of these processes. Stem cell therapies are established in clinical medicine for malignant as well as for non-malignant conditions and novel therapies are continuously being developed, several of which had entered in preclinical and clinical trials. Research projects with relevance within the broadly defined area of stem cell research are eligible.

Evaluation criteria and weights

Evaluation of quality and feasibility of the project 33%

5 = Outstanding

4 = Excellent

3 = Very good 

2 =Good

1 = Insufficient

Evaluation of the originality of the project 33%

5 = Outstanding

4 = Excellent

3 = Very good 

2 = Good

1 = Insufficient

Evaluation of the quality and merits of the scientist 33%. For junior applicants evaluation of the applicant´s potential to start an independent and successful line of research

5 = Outstanding

4 = Excellent

3 = Very good 

2 = Good

1 = Insufficient

Application

Each application must be supported by a letter from the head of department, who will thereby ascertain that the applicant holds or will hold a 100% position at KI/SLL. If several departments are involved, each head of department should support the application.

  • Project description (6 pages, Times roman, 12 points, single space, 2 cm margin), covering: Summary (limit 200 words), Objectives, Introduction, Preliminary results, Experimental plan, Significance for the field and references.
  • CV, max 2 pages. Mark whether within 12 years from PhD.
  • List of publications, highlighting the 10 most relevant publications of the main applicant
  • Budget description

The application should be submitted as a single pdf to Sri Sahlin, Karolinska Institutet (Sri.Sahlin@ki.se)

Application deadline: March 7th 2021

Decisions will be announced before May 1st 2021